{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:44:33Z","timestamp":1773283473248,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["99-1-101-43351"],"award-info":[{"award-number":["99-1-101-43351"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Schizophrenia is a severe, disabling psychiatric disorder with unclear etiology. Family-based, twins, and adoption studies have shown that genetic factors have major contributions in schizophrenia occurrence. Until now, many studies have discovered the association of schizophrenia and its comorbid symptoms with functional polymorphisms that lie within serotonin reuptake pathway genes. Here, we aimed to investigate the association of three variable number tandem repeats (VNTR) functional polymorphisms in <jats:italic>MAOA<\/jats:italic> and <jats:italic>SLC6A4<\/jats:italic> with schizophrenia in the Iranian population. Two hundred and forty-one subjects with schizophrenia and three hundred and seventy age and sex-matched healthy controls were genotyped for <jats:italic>MAOA<\/jats:italic> promoter uVNTR, 5-HTTLPR, and STin2 polymorphisms. Genotyping was performed by polymerase chain reaction (PCR) with locus-specific primers and running the PCR product on agarose 2.5% gel electrophoresis. Finally, the statistical inference was performed using R programming language and Haploview software. <jats:italic>MAOA<\/jats:italic> promoter uVNTR analysis of allele frequency showed no differences between schizophrenia subjects and healthy controls in both males and females and no significant differences were observed between female cases and female controls in <jats:italic>MAOA<\/jats:italic> promoter uVNTR 4 repeat frequency. Also, there were no differences between Schizophrenia and healthy control groups in 5-HTTLPR allele and genotype frequency but, 5-HTTLPR S allele carriers are significantly more frequent among cases. In addition, STin2.12 repeats were significantly more frequent among schizophrenia patients. Genotype comparison suggested that 5-HTTLPR S allele and STin2.12 repeat carriers were significantly more frequent among schizophrenia cases and being STin2.12 repeat carrier significantly increase the risk of schizophrenia occurrence. Besides, analysis of haplotype showed stronger linkage disequilibrium between 5-HTTLPR and STin2 haplotype block in cases than controls. These results suggest that <jats:italic>SLC6A4<\/jats:italic> functional polymorphisms potentially could play a possible role as risk factors for the incidence of schizophrenia.<\/jats:p>","DOI":"10.1038\/s41598-022-05206-x","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T11:03:10Z","timestamp":1643108590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Serotonin transporter functional polymorphisms potentially increase risk of schizophrenia separately and as a haplotype"],"prefix":"10.1038","volume":"12","author":[{"given":"Rana","family":"Ghamari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Yazarlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Khosravizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Moradkhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaheh","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"5206_CR1","doi-asserted-by":"publisher","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","volume":"1","author":"RS Kahn","year":"2015","unstructured":"Kahn, R. S. et al. Schizophrenia. Nat. Rev. Dis. Primers 1, 15067. https:\/\/doi.org\/10.1038\/nrdp.2015.67 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"5206_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/s0140-6736(09)60072-6","volume":"373","author":"P Lichtenstein","year":"2009","unstructured":"Lichtenstein, P. et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet 373, 234\u2013239. https:\/\/doi.org\/10.1016\/s0140-6736(09)60072-6 (2009).","journal-title":"Lancet"},{"issue":"Suppl 1","key":"5206_CR3","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1038\/sj.bjp.0706473","volume":"147","author":"CA Marsden","year":"2006","unstructured":"Marsden, C. A. Dopamine: The rewarding years. Br. J. Pharmacol. 147(Suppl 1), S136-144. https:\/\/doi.org\/10.1038\/sj.bjp.0706473 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"5206_CR4","first-page":"349","volume":"3","author":"M Hamon","year":"1990","unstructured":"Hamon, M. et al. The main features of central 5-HT1 receptors. Neuropsychopharmacology 3, 349\u2013360 (1990).","journal-title":"Neuropsychopharmacology"},{"key":"5206_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/ndt.s190563","volume":"15","author":"FL Xu","year":"2019","unstructured":"Xu, F. L., Wang, B. J. & Yao, J. Association between the SLC6A4 gene and schizophrenia: An updated meta-analysis. Neuropsychiatr. Dis. Treat. 15, 143\u2013155. https:\/\/doi.org\/10.2147\/ndt.s190563 (2019).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"5206_CR6","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","volume":"274","author":"KP Lesch","year":"1996","unstructured":"Lesch, K. P. et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (New York N. Y.) 274, 1527\u20131531. https:\/\/doi.org\/10.1126\/science.274.5292.1527 (1996).","journal-title":"Science (New York N. Y.)"},{"key":"5206_CR7","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1038\/tp.2011.29","volume":"1","author":"A Kobiella","year":"2011","unstructured":"Kobiella, A. et al. How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: The roles of in vivo serotonin transporter expression and amygdala structure. Transl. Psychiatry 1, e37\u2013e37. https:\/\/doi.org\/10.1038\/tp.2011.29 (2011).","journal-title":"Transl. Psychiatry"},{"key":"5206_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11033-014-3800-7","volume":"42","author":"J Culej","year":"2015","unstructured":"Culej, J., \u0160tefanovi\u0107, M., \u0106elap, I., Nikolac, N. & Karlovi\u0107, D. Serotonin transporter polymorphism (5-HTTLPR) in Croatian population. Mol. Biol. Rep. 42, 553\u2013558. https:\/\/doi.org\/10.1007\/s11033-014-3800-7 (2015).","journal-title":"Mol. Biol. Rep."},{"key":"5206_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s004390050816","volume":"103","author":"SZ Sabol","year":"1998","unstructured":"Sabol, S. Z., Hu, S. & Hamer, D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum. Genet. 103, 273\u2013279. https:\/\/doi.org\/10.1007\/s004390050816 (1998).","journal-title":"Hum. Genet."},{"key":"5206_CR10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/0888-7543(89)90279-6","volume":"4","author":"NC Lan","year":"1989","unstructured":"Lan, N. C. et al. Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease. Genomics 4, 552\u2013559. https:\/\/doi.org\/10.1016\/0888-7543(89)90279-6 (1989).","journal-title":"Genomics"},{"key":"5206_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psychres.2018.04.036","volume":"265","author":"A Mohammadi","year":"2018","unstructured":"Mohammadi, A., Rashidi, E. & Amooeian, V. G. Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia. Psychiatry Res. 265, 25\u201338. https:\/\/doi.org\/10.1016\/j.psychres.2018.04.036 (2018).","journal-title":"Psychiatry Res."},{"key":"5206_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.schres.2016.10.020","volume":"182","author":"JH Kim","year":"2017","unstructured":"Kim, J. H. et al. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [(11)C]DASB and [(18)F]FDG. Schizophr. Res. 182, 55\u201365. https:\/\/doi.org\/10.1016\/j.schres.2016.10.020 (2017).","journal-title":"Schizophr. Res."},{"key":"5206_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0888-7543(05)80286-1","volume":"14","author":"ZY Chen","year":"1992","unstructured":"Chen, Z. Y., Powell, J. F., Hsu, Y. P., Breakefield, X. O. & Craig, I. W. Organization of the human monoamine oxidase genes and long-range physical mapping around them. Genomics 14, 75\u201382. https:\/\/doi.org\/10.1016\/s0888-7543(05)80286-1 (1992).","journal-title":"Genomics"},{"key":"5206_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1134\/S1022795411060056","volume":"47","author":"NP Babushkina","year":"2011","unstructured":"Babushkina, N. P. & Kucher, A. N. Functional role of VNTR polymorphism of human genes. Russ. J. Genet. 47, 637\u2013645. https:\/\/doi.org\/10.1134\/S1022795411060056 (2011).","journal-title":"Russ. J. Genet."},{"key":"5206_CR15","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1093\/nar\/gkab224","volume":"49","author":"M Eslami Rasekh","year":"2021","unstructured":"Eslami Rasekh, M., Hern\u00e1ndez, Y., Drinan, S. D., Fuxman Bass, J. I. & Benson, G. Genome-wide characterization of human minisatellite VNTRs: Population-specific alleles and gene expression differences. Nucl. Acids Res. 49, 4308\u20134324. https:\/\/doi.org\/10.1093\/nar\/gkab224 (2021).","journal-title":"Nucl. Acids Res."},{"key":"5206_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/jhg.2009.76","volume":"54","author":"NN Vijayan","year":"2009","unstructured":"Vijayan, N. N. et al. Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population. J. Hum. Genet. 54, 538\u2013542. https:\/\/doi.org\/10.1038\/jhg.2009.76 (2009).","journal-title":"J. Hum. Genet."},{"key":"5206_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.26","volume":"1","author":"H Sugawara","year":"2011","unstructured":"Sugawara, H. et al. Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins. Transl. Psychiatry 1, e24. https:\/\/doi.org\/10.1038\/tp.2011.26 (2011).","journal-title":"Transl. Psychiatry"},{"key":"5206_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.1071829","volume":"297","author":"AR Hariri","year":"2002","unstructured":"Hariri, A. R. et al. Serotonin transporter genetic variation and the response of the human amygdala. Science (New York N. Y.) 297, 400\u2013403. https:\/\/doi.org\/10.1126\/science.1071829 (2002).","journal-title":"Science (New York N. Y.)"},{"key":"5206_CR19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1086\/503850","volume":"78","author":"XZ Hu","year":"2006","unstructured":"Hu, X. Z. et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 78, 815\u2013826. https:\/\/doi.org\/10.1086\/503850 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"5206_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10519-005-9017-8","volume":"36","author":"JR Wendland","year":"2006","unstructured":"Wendland, J. R. et al. Differential functional variability of serotonin transporter and monoamine oxidase A genes in macaque species displaying contrasting levels of aggression-related behavior. Behav. Genet. 36, 163\u2013172. https:\/\/doi.org\/10.1007\/s10519-005-9017-8 (2006).","journal-title":"Behav. Genet."},{"key":"5206_CR21","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1046\/j.1471-4159.1996.66062621.x","volume":"66","author":"A Heils","year":"1996","unstructured":"Heils, A. et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66, 2621\u20132624. https:\/\/doi.org\/10.1046\/j.1471-4159.1996.66062621.x (1996).","journal-title":"J. Neurochem."},{"key":"5206_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/bf01281159","volume":"102","author":"A Heils","year":"1995","unstructured":"Heils, A. et al. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J. Neural Transm. Gen. Sect. 102, 247\u2013254. https:\/\/doi.org\/10.1007\/bf01281159 (1995).","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"5206_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/NDT.S190563","volume":"15","author":"F-L Xu","year":"2018","unstructured":"Xu, F.-L., Wang, B.-J. & Yao, J. Association between the SLC6A4 gene and schizophrenia: An updated meta-analysis. Neuropsychiatr. Dis. Treat. 15, 143\u2013155 (2018).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"5206_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/sj.mp.4000839","volume":"6","author":"P Semwal","year":"2001","unstructured":"Semwal, P. et al. Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia. Mol. Psychiatry 6, 220\u2013224. https:\/\/doi.org\/10.1038\/sj.mp.4000839 (2001).","journal-title":"Mol. Psychiatry"},{"key":"5206_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jad.2016.10.020","volume":"208","author":"V Golimbet","year":"2017","unstructured":"Golimbet, V., Korovaitseva, G., Lezheiko, T., Abramova, L. I. & Kaleda, V. G. The serotonin transporter gene 5-HTTLPR polymorphism is associated with affective psychoses but not with schizophrenia: A large-scale study in the Russian population. J. Affect. Disord. 208, 604\u2013609. https:\/\/doi.org\/10.1016\/j.jad.2016.10.020 (2017).","journal-title":"J. Affect. Disord."},{"key":"5206_CR26","first-page":"537","volume":"36","author":"J Xu-xiu","year":"2016","unstructured":"Xu-xiu, J. et al. Study on the correlation between the polymorphism in promoter region of 5-hydroxytryptamine transporter gene and schizophrenia in Chinese Han population. J. Shanghai Jiaotong Univ. (Med. Sci.) 36, 537 (2016).","journal-title":"J. Shanghai Jiaotong Univ. (Med. Sci.)"},{"key":"5206_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/bf01276434","volume":"95","author":"KP Lesch","year":"1994","unstructured":"Lesch, K. P. et al. Organization of the human serotonin transporter gene. J. Neural Transm. Gen. Sect. 95, 157\u2013162. https:\/\/doi.org\/10.1007\/bf01276434 (1994).","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"5206_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.mp.4000821","volume":"6","author":"R Kaiser","year":"2001","unstructured":"Kaiser, R. et al. Serotonin transporter polymorphisms: No association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Mol. Psychiatry 6, 179\u2013185. https:\/\/doi.org\/10.1038\/sj.mp.4000821 (2001).","journal-title":"Mol. Psychiatry"},{"key":"5206_CR29","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1523\/jneurosci.1150-04.2004","volume":"24","author":"E Klenova","year":"2004","unstructured":"Klenova, E. et al. YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders. J. Neurosci. Off. J. Soc. Neurosci. 24, 5966\u20135973. https:\/\/doi.org\/10.1523\/jneurosci.1150-04.2004 (2004).","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"5206_CR30","doi-asserted-by":"publisher","first-page":"15251","DOI":"10.1073\/pnas.96.26.15251","volume":"96","author":"A MacKenzie","year":"1999","unstructured":"MacKenzie, A. & Quinn, J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc. Natl. Acad. Sci. U. S. A. 96, 15251\u201315255. https:\/\/doi.org\/10.1073\/pnas.96.26.15251 (1999).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"5206_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2017.12.004","volume":"82","author":"CKF Gomes","year":"2018","unstructured":"Gomes, C. K. F. et al. Association analysis of SLC6A4 and HTR2A genes with obsessive\u2013compulsive disorder: Influence of the STin2 polymorphism. Compr. Psychiatry 82, 1\u20136. https:\/\/doi.org\/10.1016\/j.comppsych.2017.12.004 (2018).","journal-title":"Compr. Psychiatry"},{"key":"5206_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/YPG.0b013e328304deb8","volume":"18","author":"AV Kazantseva","year":"2008","unstructured":"Kazantseva, A. V. et al. Polymorphisms of the serotonin transporter gene (5-HTTLPR, A\/G SNP in 5-HTTLPR, and STin2 VNTR) and their relation to personality traits in healthy individuals from Russia. Psychiatr. Genet. 18, 167\u2013176. https:\/\/doi.org\/10.1097\/YPG.0b013e328304deb8 (2008).","journal-title":"Psychiatr. Genet."},{"key":"5206_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000106477","volume":"55","author":"A Fresan","year":"2007","unstructured":"Fresan, A. et al. Association study of MAO-A and DRD4 genes in schizophrenic patients with aggressive behavior. Neuropsychobiology 55, 171\u2013175. https:\/\/doi.org\/10.1159\/000106477 (2007).","journal-title":"Neuropsychobiology"},{"key":"5206_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ajmg.b.30021","volume":"128b","author":"S Zammit","year":"2004","unstructured":"Zammit, S. et al. Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatric Genet. 128b, 19\u201320. https:\/\/doi.org\/10.1002\/ajmg.b.30021 (2004).","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatric Genet."},{"key":"5206_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/b978-0-12-386467-3.00002-9","volume":"100","author":"M Bortolato","year":"2011","unstructured":"Bortolato, M. & Shih, J. C. Behavioral outcomes of monoamine oxidase deficiency: Preclinical and clinical evidence. Int. Rev. Neurobiol. 100, 13\u201342. https:\/\/doi.org\/10.1016\/b978-0-12-386467-3.00002-9 (2011).","journal-title":"Int. Rev. Neurobiol."},{"key":"5206_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1126\/science.8211186","volume":"262","author":"HG Brunner","year":"1993","unstructured":"Brunner, H. G., Nelen, M., Breakefield, X. O., Ropers, H. H. & van Oost, B. A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science (New York N. Y.) 262, 578\u2013580. https:\/\/doi.org\/10.1126\/science.8211186 (1993).","journal-title":"Science (New York N. Y.)"},{"key":"5206_CR37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12031-018-1044-z","volume":"64","author":"M Manca","year":"2018","unstructured":"Manca, M. et al. The regulation of monoamine oxidase A gene expression by distinct variable number tandem repeats. J. Mol. Neurosci. 64, 459\u2013470. https:\/\/doi.org\/10.1007\/s12031-018-1044-z (2018).","journal-title":"J. Mol. Neurosci."},{"key":"5206_CR38","doi-asserted-by":"publisher","first-page":"852949","DOI":"10.5402\/2012\/852949","volume":"2012","author":"B Camarena","year":"2012","unstructured":"Camarena, B. et al. Monoamine oxidase a and B gene polymorphisms and negative and positive symptoms in schizophrenia. ISRN Psychiatry 2012, 852949. https:\/\/doi.org\/10.5402\/2012\/852949 (2012).","journal-title":"ISRN Psychiatry"},{"key":"5206_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ajmg.b.32009","volume":"159b","author":"Y Sun","year":"2012","unstructured":"Sun, Y. et al. Study of a possible role of the monoamine oxidase A (MAOA) gene in paranoid schizophrenia among a Chinese population. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatric Genet. 159b, 104\u2013111. https:\/\/doi.org\/10.1002\/ajmg.b.32009 (2012).","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatric Genet."},{"key":"5206_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/psychiatry.IndianJPsychiatry_54_19","volume":"62","author":"J Culej","year":"2020","unstructured":"Culej, J., Nikolac Gabaj, N., \u0160tefanovi\u0107, M. & Karlovi\u0107, D. Prediction of schizophrenia using MAOA-uVNTR polymorphism: A case\u2013control study. Indian J. Psychiatry 62, 80\u201386. https:\/\/doi.org\/10.4103\/psychiatry.IndianJPsychiatry_54_19 (2020).","journal-title":"Indian J. Psychiatry"},{"key":"5206_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2008.08.063","volume":"1240","author":"S Guhathakurta","year":"2008","unstructured":"Guhathakurta, S. et al. Population-based association study and contrasting linkage disequilibrium pattern reveal genetic association of SLC6A4 with autism in the Indian population from West Bengal. Brain Res. 1240, 12\u201321. https:\/\/doi.org\/10.1016\/j.brainres.2008.08.063 (2008).","journal-title":"Brain Res."},{"key":"5206_CR42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00438-018-1415-8","volume":"293","author":"F Alizadeh","year":"2018","unstructured":"Alizadeh, F., Bozorgmehr, A., Tavakkoly-Bazzaz, J. & Ohadi, M. Skewing of the genetic architecture at the ZMYM3 human-specific 5\u2032 UTR short tandem repeat in schizophrenia. Mol. Genet. Genom. MGG 293, 747\u2013752. https:\/\/doi.org\/10.1007\/s00438-018-1415-8 (2018).","journal-title":"Mol. Genet. Genom. MGG"},{"key":"5206_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jad.2005.12.048","volume":"91","author":"X Gonda","year":"2006","unstructured":"Gonda, X. et al. The 5HTTLPR polymorphism of the serotonin transporter gene is associated with affective temperaments as measured by TEMPS-A. J. Affect. Disord. 91, 125\u2013131 (2006).","journal-title":"J. Affect. Disord."},{"key":"5206_CR44","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.3390\/ijerph120303317","volume":"12","author":"A Samochowiec","year":"2015","unstructured":"Samochowiec, A. et al. Monoamine oxidase a promoter variable number of tandem repeats (MAOA-uVNTR) in alcoholics according to Lesch typology. Int. J. Environ. Res. Public Health 12, 3317\u20133326 (2015).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"5206_CR45","first-page":"1","volume":"15","author":"MRP de Castro","year":"2014","unstructured":"de Castro, M. R. P. et al. SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: A case control study. BMC Genet. 15, 1\u20139 (2014).","journal-title":"BMC Genet."},{"key":"5206_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 21, 263\u2013265. https:\/\/doi.org\/10.1093\/bioinformatics\/bth457 (2005).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"5206_CR47","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/jhg.2011.39","volume":"56","author":"J-E De Neve","year":"2011","unstructured":"De Neve, J.-E. Functional polymorphism (5-HTTLPR) in the serotonin transporter gene is associated with subjective well-being: Evidence from a US nationally representative sample. J. Hum. Genet. 56, 456\u2013459. https:\/\/doi.org\/10.1038\/jhg.2011.39 (2011).","journal-title":"J. Hum. Genet."},{"key":"5206_CR48","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/sj.mp.4001690","volume":"10","author":"JB Fan","year":"2005","unstructured":"Fan, J. B. & Sklar, P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol. Psychiatry 10, 928\u2013938. https:\/\/doi.org\/10.1038\/sj.mp.4001690 (2005).","journal-title":"Mol. Psychiatry"},{"key":"5206_CR49","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/7854_2011_186","volume":"12","author":"K Haddley","year":"2012","unstructured":"Haddley, K., Bubb, V. J., Breen, G., Parades-Esquivel, U. M. & Quinn, J. P. Behavioural genetics of the serotonin transporter. Curr. Top. Behav. Neurosci. 12, 503\u2013535. https:\/\/doi.org\/10.1007\/7854_2011_186 (2012).","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"5206_CR50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jad.2018.06.035","volume":"238","author":"WT Kao","year":"2018","unstructured":"Kao, W. T., Chang, C. L. & Lung, F. W. 5-HTT mRNA level as a potential biomarker of treatment response in patients with major depression in a clinical trial. J. Affect. Disord. 238, 597\u2013608. https:\/\/doi.org\/10.1016\/j.jad.2018.06.035 (2018).","journal-title":"J. Affect. Disord."},{"key":"5206_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ajmg.b.30184","volume":"136b","author":"K S\u00f8eby","year":"2005","unstructured":"S\u00f8eby, K., Larsen, S. A., Olsen, L., Rasmussen, H. B. & Werge, T. Serotonin transporter: Evolution and impact of polymorphic transcriptional regulation. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatric Genet. 136b, 53\u201357. https:\/\/doi.org\/10.1002\/ajmg.b.30184 (2005).","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatric Genet."},{"key":"5206_CR52","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/s41467-021-22206-z","volume":"12","author":"M Bakhtiari","year":"2021","unstructured":"Bakhtiari, M. et al. Variable number tandem repeats mediate the expression of proximal genes. Nat. Commun. 12, 2075. https:\/\/doi.org\/10.1038\/s41467-021-22206-z (2021).","journal-title":"Nat. Commun."},{"key":"5206_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pnpbp.2017.04.011","volume":"77","author":"V Peitl","year":"2017","unstructured":"Peitl, V., \u0160tefanovi\u0107, M. & Karlovi\u0107, D. Depressive symptoms in schizophrenia and dopamine and serotonin gene polymorphisms. Prog. Neuropsychopharmacol. Biol. Psychiatry 77, 209\u2013215. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.04.011 (2017).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"5206_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.neulet.2011.09.036","volume":"504","author":"CF Hung","year":"2011","unstructured":"Hung, C. F. et al. Association between suicide attempt and a tri-allelic functional polymorphism in serotonin transporter gene promoter in Chinese patients with schizophrenia. Neurosci. Lett. 504, 242\u2013246. https:\/\/doi.org\/10.1016\/j.neulet.2011.09.036 (2011).","journal-title":"Neurosci. Lett."},{"key":"5206_CR55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jpsychires.2012.03.008","volume":"46","author":"N Bo\u017eina","year":"2012","unstructured":"Bo\u017eina, N. et al. Suicide ideators and attempters with schizophrenia\u2014The role of 5-HTTLPR, rs25531, and 5-HTT VNTR Intron 2 variants. J. Psychiatr. Res. 46, 767\u2013773. https:\/\/doi.org\/10.1016\/j.jpsychires.2012.03.008 (2012).","journal-title":"J. Psychiatr. Res."},{"key":"5206_CR56","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1471-4159.2009.06453.x","volume":"112","author":"FR Ali","year":"2010","unstructured":"Ali, F. R. et al. Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF. J. Neurochem. 112, 296\u2013306. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06453.x (2010).","journal-title":"J. Neurochem."},{"key":"5206_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/YPG.0b013e32835d6fad","volume":"23","author":"H Tharoor","year":"2013","unstructured":"Tharoor, H., Kotambail, A., Jain, S., Sharma, P. S. & Satyamoorthy, K. Study of the association of serotonin transporter triallelic 5-HTTLPR and STin2 VNTR polymorphisms with lithium prophylaxis response in bipolar disorder. Psychiatr. Genet. 23, 77\u201381. https:\/\/doi.org\/10.1097\/YPG.0b013e32835d6fad (2013).","journal-title":"Psychiatr. Genet."},{"key":"5206_CR58","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000096041","volume":"54","author":"D Gaysina","year":"2006","unstructured":"Gaysina, D., Zainullina, A., Gabdulhakov, R. & Khusnutdinova, E. The serotonin transporter gene: Polymorphism and haplotype analysis in Russian suicide attempters. Neuropsychobiology 54, 70\u201374. https:\/\/doi.org\/10.1159\/000096041 (2006).","journal-title":"Neuropsychobiology"},{"key":"5206_CR59","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ajmg.b.30597","volume":"147","author":"G Zaboli","year":"2008","unstructured":"Zaboli, G. et al. Haplotype analysis confirms association of the serotonin transporter (5-HTT) gene with schizophrenia but not with major depression. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatric Genet. 147, 301\u2013307. https:\/\/doi.org\/10.1002\/ajmg.b.30597 (2008).","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatric Genet."},{"key":"5206_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1176\/appi.ajp.157.2.275","volume":"157","author":"HM Conklin","year":"2000","unstructured":"Conklin, H. M., Curtis, C. E., Katsanis, J. & Iacono, W. G. Verbal working memory impairment in schizophrenia patients and their first-degree relatives: Evidence from the digit span task. Am. J. Psychiatry 157, 275\u2013277. https:\/\/doi.org\/10.1176\/appi.ajp.157.2.275 (2000).","journal-title":"Am. J. Psychiatry"},{"key":"5206_CR61","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1503\/jpn.100085","volume":"36","author":"G Horga","year":"2011","unstructured":"Horga, G. et al. Differential brain glucose metabolic patterns in antipsychotic-na\u00efve first-episode schizophrenia with and without auditory verbal hallucinations. J. Psychiatry Neurosci. JPN 36, 312\u2013321. https:\/\/doi.org\/10.1503\/jpn.100085 (2011).","journal-title":"J. Psychiatry Neurosci. JPN"},{"key":"5206_CR62","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/schbul\/sbaa075","volume":"46","author":"T Ikegame","year":"2020","unstructured":"Ikegame, T. et al. Promoter activity-based case\u2013control association study on SLC6A4 highlighting hypermethylation and altered amygdala volume in male patients with schizophrenia. Schizophr. Bull. 46, 1577\u20131586. https:\/\/doi.org\/10.1093\/schbul\/sbaa075 (2020).","journal-title":"Schizophr. Bull."},{"key":"5206_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pscychresns.2016.02.006","volume":"250","author":"AM Rich","year":"2016","unstructured":"Rich, A. M. et al. Amygdala volume is reduced in early course schizophrenia. Psychiatry Res. Neuroimaging 250, 50\u201360. https:\/\/doi.org\/10.1016\/j.pscychresns.2016.02.006 (2016).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"5206_CR64","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/s0168-9525(01)02366-6","volume":"17","author":"R Ohlsson","year":"2001","unstructured":"Ohlsson, R., Renkawitz, R. & Lobanenkov, V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet. TIG 17, 520\u2013527. https:\/\/doi.org\/10.1016\/s0168-9525(01)02366-6 (2001).","journal-title":"Trends Genet. TIG"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05206-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05206-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05206-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:37:55Z","timestamp":1669325875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05206-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5206"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05206-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1336"}}